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Carbonyl reductases are an important group of enzymes that participate in metabolism 
of both endogenous substances also xenobiotics. Potential anticancer drug oracin is one of 
such xenobiotics that is metabolised by various carbonyl reductases to two enantiomers of 
dihydrooracin. The new human microsomal carbonyl reductase also takes part in 
biotransformation of oracin. This enzyme was recently purified on Department of biochemical 
sciences (Faculty of Pharmacy in Hradec Králové). The aim of this study was to find some 
inhibitors of the new enzyme and distinguish it in terms of inhibitors from another 
microsomal carbonyl reductase 11β-hydroxysteroid dehydrogenase 1.  
Flavonoids are substances produced by plants, they have a different both positive and 
also negative effect on human organism. One of such effect is inhibition effect on diverse 
enzymes. Carbonyl reductases also fall in this group. It has been described inhibitory effect of 
different flavonoids on carbonyl reductases.  
Inhibition study of the new human micorosomal carbonylreductase was made with a 
group of flavonoids. The strongest inhibitor from the group of substances was quercetin and 
further apigenin, silibinin, luteolin, chlorogenic acid and rutin. Effect of quercetin and also 
18β-glycyrrhetinic acid (an inhibitor of 11β-hydroxysteroid dehydrogenase 1) on 
biotransformation of oracin in whole human liver micorosomal fraction was also determined.  
 
